Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03854110
Title Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Geistlich Pharma AG
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.